A study of dermatological efficacy after continuous application of topical product (CDM050) in human ski

Not Applicable

• Conditions: Healthy adults

• Registration Number: JPRN-UMIN000025668
• Lead Sponsor: Kao Corporation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-01-16
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Female
• Target Recruitment: 8

Inclusion Criteria

Not provided

Exclusion Criteria

1.Known allergies to skin care products. 2.Nursing, pregnant, or planning to become pregnant during the study according to subject self-report. 3.A history of skin cancer, having active skin cancer. 4.Diagnosed as having keloid diathesis. 5.A medically diagnosed acute or chronic hepatitis B and hepatitis C. 6.A recent or current history of inflammatory skin disease, infection, cancerous/pre-cancerous lesion, unhealed wound or clinically significant acne in the proposed treatment areas. Individuals who have a history of systemic granulomatous diseases, active or inactive, or connective tissue diseases. 7.A health condition and/or pre-existing or dormant dermatologic disease on the upper arms that the Investigator or designee deems inappropriate for participation or could interfere with the outcome of the study. 8.Observable suntan, scars, nevi, excessive hair, etc., varicose veins, rashes, compromised, broken skin, scarring, tattoos, or other dermal conditions on the upper forearms that might influence the test results in the opinion of the Investigator or designee. 9.A history of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or currently using immunosuppressive medications and/or radiation as determined by study documentation. 10.An uncontrolled disease such as asthma, diabetes, hypertension, hyperthyroidism, or hypothyroidism. Individuals having multiple health conditions may be excluded from participation even if the conditions are controlled by diet, medication, etc. 11.Any planned surgeries and/or invasive medical procedures during the course of the study. 12.Currently participating in any other clinical trial at Stephens, another research facility or doctor's office or have participated in any clinical trial involving the test area within 4 weeks prior to inclusion into the study at Stephens, at another research facility or doctor's office.

Study & Design

• Study Type: Interventional
• Study Design: Not specified